<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02238340</url>
  </required_header>
  <id_info>
    <org_study_id>Oxycodone</org_study_id>
    <nct_id>NCT02238340</nct_id>
  </id_info>
  <brief_title>Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery</brief_title>
  <official_title>Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Central Dr. Luis Ortega</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Central Dr. Luis Ortega</source>
  <brief_summary>
    <textblock>
      Inadequate control of acute postoperative pain (DAPO) brings deleterious consequences for the
      patient, including significant cardiovascular and respiratory complications. Apart from the
      human suffering that is undeniable pain. Schemes oral analgesia with opioids for the
      treatment of DAPO, have shown to be as or more effective than intravenous or epidural
      regimes, and less expensive. Comparing the effectiveness of 10 to 20 mgs of oxycodone
      sustained release for 12 hours before surgery, into two groups of 20 patients (O-10, O-20)
      undergoing orthopedic surgery, in a scheme involving multimodal ketoprofen, dipyrone
      metoclopramide and dexamethasone. Values were recorded visual analog scale (VAS)for pain at
      rest and effort, requirement for rescue intravenous morphine and incidence of side effects to
      the entry and exit of the PACU (T0, TE) and at 6 and 18 hours postoperatively (T6, T18),and
      patient satisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percents of patients with EVA &lt; 4 to the alt of UCPA, and 6 , 18 postoperatory hours</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percents of patients with adverse events because of treatment</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extended-release oxycodone 10 mgrs , started 12 hours before orthopaedic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extended-release oxycodone 20 mgr , started 12 hours before orthopaedic surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended-release oxycodone</intervention_name>
    <description>10 o 20 mgrs of extended-release oxycodone ,started 12 hours before orthopaedic surgery</description>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended- release Oxycodone</intervention_name>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketoprofen</intervention_name>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
    <other_name>Both groups received ketoprofen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dipirone</intervention_name>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
    <other_name>Both groups received dipirone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexametasone</intervention_name>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
    <other_name>Both groups received dexametasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine IV (rescue)</intervention_name>
    <arm_group_label>Extended-release oxycodone 10mgr</arm_group_label>
    <arm_group_label>Extended-release oxycodone 20 mgr</arm_group_label>
    <other_name>Both groups received Morphine IV (rescue)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I and II patients between 18 and 60 years old, both sexes, undergoing elective
             orthopedic surgery.

        Exclusion Criteria:

          -  Use of psychotropic medication or illicit drug use

          -  Pregnancy

          -  Liver disease

          -  Opioid use

          -  History of postoperative nausea and vomiting

          -  Ileus

          -  Allergy or intolerance to any of the study drugs

          -  Physical or mental inability to use the pain scale, or any surgical complications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatriz S Arismendi Gomez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sociedad Venezolana de Anestesiologia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Servicio de Aestesiologia.Hospital &quot;Dr Luis Ortega&quot;</name>
      <address>
        <city>Porlamar</city>
        <state>Nueva Esparta</state>
        <zip>6301</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Venezuela</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2014</study_first_submitted>
  <study_first_submitted_qc>September 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2014</study_first_posted>
  <last_update_submitted>September 11, 2014</last_update_submitted>
  <last_update_submitted_qc>September 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Central Dr. Luis Ortega</investigator_affiliation>
    <investigator_full_name>Beatriz Arismendi GÃ³mez</investigator_full_name>
    <investigator_title>Medico Anestesiologo</investigator_title>
  </responsible_party>
  <keyword>Postoperatory pain</keyword>
  <keyword>Oxycodone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

